CC BY 4.0 · Arq Neuropsiquiatr 2025; 83(07): s00451809882
DOI: 10.1055/s-0045-1809882
Original Article

Supera cognitive stimulation study with cognitively-unimpaired older adults: methodology and initial results of a randomized controlled clinical trial

1   Universidade de São Paulo, Escola de Artes, Ciências e Humanidades, Programa de Pós-Graduação em Gerontologia, São Paulo SP, Brazil.
,
1   Universidade de São Paulo, Escola de Artes, Ciências e Humanidades, Programa de Pós-Graduação em Gerontologia, São Paulo SP, Brazil.
,
1   Universidade de São Paulo, Escola de Artes, Ciências e Humanidades, Programa de Pós-Graduação em Gerontologia, São Paulo SP, Brazil.
,
1   Universidade de São Paulo, Escola de Artes, Ciências e Humanidades, Programa de Pós-Graduação em Gerontologia, São Paulo SP, Brazil.
,
1   Universidade de São Paulo, Escola de Artes, Ciências e Humanidades, Programa de Pós-Graduação em Gerontologia, São Paulo SP, Brazil.
,
1   Universidade de São Paulo, Escola de Artes, Ciências e Humanidades, Programa de Pós-Graduação em Gerontologia, São Paulo SP, Brazil.
,
1   Universidade de São Paulo, Escola de Artes, Ciências e Humanidades, Programa de Pós-Graduação em Gerontologia, São Paulo SP, Brazil.
,
1   Universidade de São Paulo, Escola de Artes, Ciências e Humanidades, Programa de Pós-Graduação em Gerontologia, São Paulo SP, Brazil.
,
2   Universidade de São Paulo, Faculdade de Medicina, Departamento de Neurologia, Divisão de Clínica Neurológica, Grupo de Neurologia Cognitiva e do Comportamento, São Paulo SP, Brazil.
,
1   Universidade de São Paulo, Escola de Artes, Ciências e Humanidades, Programa de Pós-Graduação em Gerontologia, São Paulo SP, Brazil.
2   Universidade de São Paulo, Faculdade de Medicina, Departamento de Neurologia, Divisão de Clínica Neurológica, Grupo de Neurologia Cognitiva e do Comportamento, São Paulo SP, Brazil.
› Author Affiliations

Funding The authors declare that the present study was funded by Supera Instituto de Educação.
 

Abstract

Scientific investigations have highlighted the benefits of cognitive stimulation for cognitive, psychological, and social aspects in older individuals. However, there is a dearth of long-term, methodologically-rigorous studies. The aim of the present study was to describe the methods and the initial characteristics of the participants in a randomized controlled trial on cognitive stimulation. A total of 578 older individuals accepted invitations to participate in the study. Of these respondents, 362 met the eligibility criteria, and 255 were selected and randomized into the training, active control, and passive control groups. During the baseline stage (T0), 48 participants withdrew, resulting in a final T0 sample of 207 participants. The three groups were similar in terms of cognitive performance and sociodemographic and psychosocial variables, but they differed significantly regarding depressive symptoms, with the training group scoring higher. The methods herein described can help guide future research on cognitive stimulation in older adults.


#

INTRODUCTION

Brain plasticity refers to the brain's capacity to form new neuronal connections in response to individual needs and the environment.[1] Cognitive stimulation seeks to activate higher cognitive functions, such as memory, reasoning, language, and executive functions, employing different resources to slow cognitive decline. Encouraging older individuals to engage in cognitively-stimulating activities has become increasingly important, with the goal of enhancing their quality of life and, as far as possible, preserve and improve brain function.[2]

Many cognitive interventions have been reported in the literature.[3] Gavelin et al.[2] identified three main types: cognitive training, cognitive rehabilitation, and cognitive stimulation. Cognitive stimulation encompasses a variety of activities aimed at preserving overall cognitive function while encouraging mental and social engagement. This type of intervention is recommended for older adults with mild-to-moderate dementia, as well as for cognitively-unimpaired individuals. These activities can be performed individually, but also in social and community settings. The present article focuses on cognitive stimulation.

Reviews and meta-analyses have demonstrated the benefits of cognitive stimulation for cognitive domains[4] as well as psychosocial aspects, through improvements in quality of life and reductions in depression and anxiety.[5] These psychosocial variables are strongly linked to cognitive performance, making it essential to maintain or improve these aspects in older adults with or without cognitive impairment.[4] Calatayud et al.[6] conducted a clinical trial involving 201 volunteers, and the results showed that the intervention group presented better cognitive performance than the control group after 10 sessions and at subsequent evaluations.

Previous studies had certain limitations, such as a lack of randomization and blinding of evaluators,[3] reinforcing the need for further research with postintervention follow-up, particularly in Brazil. Such studies can demonstrate the impact of strategies that promote cognitive health, preserve the autonomy of older adults, and reduce the burden on the social and healthcare systems.[7]

Despite the growing importance of cognitive stimulation, there is a dearth of robust studies in the literature on the efficacy of this strategy.[8] There are some challenges in identifying the reliability of results for cognitive intervention studies, such as a lack of methodological vigor, small samples, and the heterogeneity of the interventions, with most studies involving multiple intervention components besides cognitive stimulation.[9]

Other researchers have described the methodological procedures of studies involving cognitive interventions.[10] [11] [12] [13] In this respect, Zülke et al.[14] described the protocol of a study whose objective was to develop a prevention program against cognitive decline in older community-dwelling adults. Yoon et al.[15] reported the methodological characteristics of a cognitive training study in adults, together with results at baseline, including sociodemographic information on the sample. More recently, Crivelli et al.[10] reported the study design and harmonization strategies of the Latin American Initiative for Lifestyle Intervention to Prevent Cognitive Decline, providing the sociodemographic data and health status for the sample. These studies highlight the importance of describing the design of randomized controlled trials, most notably to enable reproducibility.

The objective of the Supera Cognitive Stimulation Study clinical trial was to investigate the impact of the Supera cognitive stimulation program on cognitive performance and psychosocial variables in healthy older adults. In the present article, a description of the clinical trial design is provided, along with the initial results collected at baseline between February and March 2022.


#

METHODS

Study overview

The baseline assessments before randomization (T0) have been completed ([Figure 1]), while the subsequent assessments will be conducted at 6 (T1), 12 (T2), and 18 months (T3) throughout the intervention. Finally, a follow-up assessment will be conducted 24 months postintervention (T4).

Zoom Image
Figure 1 Diagram of the Consolidated Standards of Reporting Trials (CONSORT) statement.

#

Sample selection

After publicizing the study at community centers and retiree associations in the city of São Paulo, Brazil, the study was advertised on social media platforms. The recruitment strategies included information posters, registration forms, telephone and in-person contact with retirees' associations, clubs, and cultural centers for older adults. The persons interested in participating contacted the research assistants by telephone or e-mail. The research assistants enrolled all voluntary participants for the cognitive screening and concealed their identification data using sequential coding.

However, of this initial group, 28 participants withdrew and failed to complete the process, while a further 188 were excluded due to the presence of symptoms of depression (n = 56), anxiety (n = 56), suspicion of or possible dementia (n = 2), functional impairment (n = 22), and previous participation in cognitive stimulation programs (n = 52).

The sample size was calculated, and the funding constraints, considered. A total of 362 subjects met the eligibility criteria, 255 of whom were randomly selected. Of this group, 207 agreed to participate in the study at baseline. All participants took part in the study on a voluntary basis, and the program, materials and assessments were all provided free of charge. This information was stated in the Free and Informed Consent Form (FICF) signed by all participants and researchers involved.


#

Randomization

In an effort to reduce the risk of selection bias and ensure comparability across groups, the Excel software (Microsoft Corp.) was used to perform the stratified randomization;[16] initially, the participants were grouped into 8 strata according to sex (male and female), age (older or the same as the median age of the sample and younger than the median) and level of schooling (the same or higher than the median and lower than the median).

For each stratum, a list of random numbers was generated using the “rand.” function, which enabled the participants to be allocated in random order. Based on this order, individuals were randomly assigned into the training group (TG; n = 65), the active control group (ACG; n = 63), and the passive control group (PCG; n = 79).


#

Eligibility criteria

The study included participants who were aged ≥ 60 years, had at least a primary level of schooling (4 years of formal education) and scored > 15 on the Brazilian Telephone-Based Mini-Mental State Exam (Braztel-MMSE), which indicates healthy cognitive functioning, as per the specificity and sensitivity criteria established by Camozzato et al.[17] In addition, participants had to score < 6 on the Geriatric Depression Scale (GDS),[18] which indicates absence of depression. Individuals with controlled clinical conditions or in use of medications to manage depressive or anxious symptoms were also deemed eligible, provided that their scores did not exceed the cut-off points for depression (GDS > 5) or anxiety (score > 9 on the Geriatric Anxiety Inventory, GAI).[19] To complement the functional assessment, the participants had to nominate a family member or friend to fill out the Functional Activities Questionnaire (FAQ),[20] with subsequent exclusion of individuals scoring > 2 points on it.

Moreover, individuals who were aged < 60 years, exhibited visual, hearing or motor deficits that affected their ability to perform the cognitive tasks, presented severe psychiatric disorders, clinical or neuroimaging evidence suggestive of vascular problems, or previous diagnosis of dementia, were also excluded. Most of the criteria were analyzed based on information self-reported by the participants.


#

Screening protocol and neurological assessment

The screening assessed sociodemographic variables and health conditions using the following instruments: the Sociodemographic Variables Questionnaire, the Lie/Bet Questionnaire (for pathological gambling),[21] the Braztel-MMSE,[17] the FAQ,[20] the GDS,[18] the GAI,[19] the Cut Down, Annoyed, Guilty, and Eye-Opener (CAGE; for alcohol-related issues),[22] and a questionnaire on coronavirus disease 2019 (COVID-19), vaccination, and changes in mood and anxiety.

After applying the exclusion criteria, the selected participants underwent a neuropsychological evaluation using the following instruments: the Addenbrooke's Cognitive Examination-Revised (ACE-R);[23] the Short Cognitive Test Performance (Syndrom Kurztest, SKT);[24] F-A-S Phonemic Verbal Fluency Test (FAS);[25] Digit Span Forward (DSF) and Digit Span Backward (DSB);[26] [27] Spatial Span Forward (SSF) and Spatial Span Backward (SSB);[26] [28] Letter Number Sequencing;[26] [27] the Digit Symbol Substitution Test (DSST);[29] the Trail-Making Test (TMT);[30] and the Abacus Calculation Test.[31]

Psychosocial variables were assessed using the following scales: GDS;[18] the Depression, Anxiety, and Stress Scale (DASS);[32] the Control, Autonomy, Self-realization, and Pleasure Scale (CASP-19);[33] the Minimum Map of Relationships of Older Individuals (MMROI);[34] and the Cognitive Function Instrument (CFI).[35] The evaluators were blinded to the participants' experimental condition. The assessment lasted 90 minutes.


#

Description of the interventions

Training group

The TG took part in 72 weekly sessions of 2 hours each ([Figure 2]). The Supera Stimulation Program has been described in more detail elsewhere.[36] At each session, the attendance of the participants was monitored, with a minimum presence of 80% required for each semester.

Zoom Image
Figure 2 Model of the cognitive sessions.

A script created by the program instructors outlined the strategies applied to meet the aims of each session, ranging from abacus training for mathematics calculations, folders containing a variety of cognitive exercises (such as “spot the difference”, strategy and memory activities, and visuospatial perception exercises), board games, an online platform with exercises, group dynamics, and “neurobics”.

At the end of each session, the participants were asked to carry out 30 minutes of online exercises using the Supera Online Platform and continue practicing specific skills at home until the next session. Moreover, individual goals were set for abacus-based activities and a folder containing cognitive activities and online activities for completion during the practical sessions and at home was provided.


#

Active control group (ACG)

The ACG underwent a gerontological education program with the same duration and intervention time as the TG. The purpose of this control group was to document the benefits of participating in a psychoeducation group and determine whether the gains of the TG exceeded those of the ACG.

Folders were produced and printed containing texts and questions to consolidate each topic studied. In addition, audiovisual materials to illustrate the discussions were also produced. The topics addressed were related to biopsychosocial aspects of aging and late life, promoting health and disease prevention, rights of older people, protagonism of individuals aged ≥ 60, among others.

Similar to the training group (TG), the active control group (ACG) participated in structured sessions guided by pre-defined scripts. These scripts included specific discussion topics, interactive activities to reinforce the session content, estimated time for each component, and reflective exercises assigned as homework. Unlike the TG, however, the ACG sessions focused solely on health and lifestyle education, with no direct emphasis on cognitive stimulation. Thus, the ACG adhered to the same model applied to the TG, and the minimum required attendance rate was of 80% per semester, as in the TG.


#

Passive control group

The PCG underwent no intervention of any kind, only the assessment during the same period, as the other groups.


#
#

Ethical aspects

The current study was approved by the Ethics Committee for Research in Humans of Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (HCFMUSP) under no. 4.357.429 and registered at the Brazilian Clinical Trials Registry under identification no. RBR-10wnp828. The present study complied with the guidelines of the Consolidated Standards of Reporting Trials (CONSORT) statement.

In order to avoid any conflict of interest among the parties, and given the study involved a commercially-available cognitive stimulation program, documents declaring no conflict of interest were signed. Moreover, all data were collected and analyzed by independent professionals who were not part of the program.


#

Statistical analysis

The sample profile was presented using tables with descriptive statistics, including frequencies, measures of central tendency, and measures of dispersion.

The Kolmogorov-Smirnov's test confirmed that the numeric variables had a non-normal distribution; therefore, non-parametric tests were applied. The Kruskal-Wallis test was employed to compare continuous and ordinal data among the groups. Spearman's correlations were used to analyze the relationships among the variables. The Chi-squared test was employed compare the categorical variables among the groups.

The data were keyed into Google Sheets (Google LLC) and subsequently treated and analyzed using the software applications R (R Foundation for Statistical Computing) and Statistica (TIBCO Software Inc.), version 7.0. The level of significance adopted for the statistical tests was 5% (p < 0.05).


#

Procedures

The assessments of the cognitive screening stage were performed by gerontologists, with a discussion about the clinical conditions with the researchers responsible for the current study, a neurologist, a neuropsychologist, and a gerontologist specializing in cognitive and behavioral neurology. The neuropsychological assessment lasted 90 minutes and was performed by neuropsychologists blinded to the experimental conditions of the present study but duly trained for it. The participants signed a FICF and the anonymity and confidentiality of the data at all stages of the study will be guaranteed, as well as the participants' right to withdraw from the study at any time.


#
#

RESULTS

[Table 1] shows the sociodemographic variables of the 207 participants, who were randomized as follows: TG – n = 65; ACG – n = 63; and PCG – n = 79. The participants were predominantly of the female sex (73.43%), had a mean age of 67.55 (±5.29) years, and a mean of 17.03 (±4.64) years of schooling. Regarding marital status, 48.79% reported being married. Overall, 85% of the participants stated they were pensioners or retirees. The groups were similar in terms of sociodemographic characteristics ([Table 1]).

Table 1

Sociodemographic characteristics of the study sample

Variable

Total (N = 207)

TG (n = 65)

ACG (n = 63)

PCG (n = 79)

p-value

n

Sex: n (%)

Female

152 (73.43)

50 (76.92)

47 (74.60)

55 (69.62)

0.595a

Male

55

26.57

15

23.08

16

25.40

24

30.38

Age (years)

Mean(±SD)

67.55(±5.29)

67.48(±5.35)

67.89(±5.89)

67.33(±4.75)

0.954b

Median (min.–max.)

67.00 (60.00-89.00)

67.00 (60.00-83.00)

67.00 (60.00-89.00)

67.00 (60.00-84.00)

Schooling (years)

Mean(±SD)

17.03(±4.64)

16.68(±3.95)

17.60(±5.98)

16.86(±3.91)

0.968b

Median (min.–max.)

16.00 (8.00–45.00)

16.00 (9.00–27.00)

16.00 (11.00–45.00)

17.00 (8.00–27.00)

Marital status: n (%)

Married

101 (48.79)

30 (46.15)

30 (47.62)

41 (51.90)

0.906a

Divorced

32 (15.46)

11 (16.92)

8 (12.70)

13(16.46)

Single

46 (22.22)

15 (23.08)

17 (26.98)

14 (17.72)

Widowed

28 (13.53)

9 (13.85)

8 (12.70)

11 (13.92)

Retired or pensioner: n (%)

Yes

176 (85.02)

56 (86.15)

54 (85.71)

66 (83.54)

0.894a

No

31 (14.98)

9 (13.85)

9 (14.29)

13 (16.46)

Abbreviations: ACG, active control group; max., maximum; min., minimum; PCG, passive control group; SD, standard deviation; TG, training group.


Notes: aChi-squared test; bMann-Whitney U-test.


The results of the performance on the cognitive tests are provided in [Table 2]. The scores of the groups were statistically similar. These findings suggest homogeneity of results across the three groups, that is, from a statistical standpoint, there were no notable differences in cognitive performance among the groups at the baseline assessment.

Table 2

Cognitive performance of the study sample

Variables

Group

Mean

±SD

Minimum

Median

Maximum

p-value

ACE-R

TG

89.97

±5.78

70.00

91.00

98.00

0.613ª

ACG

90.14

±6.95

47.00

91.00

98.00

PCG

90.96

±4.80

73.00

92.00

100.00

SKT

TG

3.45

±2.11

0.00

3.00

9.00

0.322ª

ACG

3.49

±2.55

0.00

3.00

12.00

PCG

3.14

±2.42

0.00

2.00

13.00

FAS: F

TG

14.46

±3.96

4.00

14.00

24.00

0.859ª

ACG

14.59

±4.03

7.00

15.00

23.00

PCG

14.35

±3.64

7.00

14.00

26.00

FAS: A

TG

13.17

±3.71

5.00

13.00

22.00

0.742ª

ACG

13.57

±3.71

4.00

14.00

22.00

PCG

13.20

±4.17

4.00

13.00

24.00

FAS: S

TG

13.65

±3.47

4.00

14.00

20.00

0.372ª

ACG

12.97

±3.57

5.00

13.00

22.00

PCG

13.62

±4.08

4.00

14.00

26.00

DSF

TG

7.97

±2.11

5.00

8.00

14.00

0.364ª

ACG

8.54

±2.94

4.00

8.00

15.00

PCG

8.65

±2.69

4.00

8.00

14.00

DSB

TG

5.54

±1.98

2.00

5.00

11.00

0.376ª

ACG

5.35

±1.92

2.00

5.00

14.00

PCG

5.78

±1.97

2.00

6.00

11.00

SSF

TG

7.65

±1.53

5.00

8.00

11.00

0.537ª

ACG

7.24

±1.94

4.00

7.00

11.00

PCG

7.35

±1.84

3.00

8.00

12.00

SSB

TG

6.26

±1.91

2.00

6.00

12.00

0.716ª

ACG

6.44

±1.95

2.00

6.00

11.00

PCG

6.51

±2.05

2.00

6.00

11.00

DSST

TG

59.15

±16.70

26.00

59.00

96.00

0.941ª

ACG

58.35

±14.53

17.00

58.00

85.00

PCG

58.75

±14.93

8.00

59.00

93.00

Letter number sequencing

TG

8.38

±2.07

4.00

8.00

14.00

0.786ª

ACG

8.25

±2.44

3.00

8.00

13.00

PCG

8.52

±2.54

2.00

8.00

14.00

TMT A: time

TG

45.18

±14.37

21.00

44.00

90.00

0.320ª

ACG

49.53

±16.86

24.00

45.07

105.00

PCG

47.58

±17.70

24.00

43.06

118.00

TMT A: errors

TG

0.26

±0.57

0.00

0.00

2.00

0.843ª

ACG

0.25

±0.76

0.00

0.00

5.00

PCG

0.29

±0.70

0.00

0.00

3.00

TMT B: time

TG

109.46

±66.10

51.00

100.00

471.00

0.137ª

ACG

111.87

±44.21

47.00

107.00

221.00

PCG

102.23

±68.86

52.00

84.00

595.00

TMT B: errors

TG

0.94

±1.31

0.00

0.00

6.00

0.928ª

ACG

1.21

±1.73

0.00

0.00

7.00

PCG

1.03

±1.68

0.00

0.00

10.00

Abacus calculation test (addition; time/number of right answers)

TG

50.42

±31.46

0.00

42.80

183.25

0.515ª

ACG

51.23

±38.87

14.88

42.00

236.00

PCG

44.70

±24.08

10.17

39.17

139.60

Abbreviations: ACE-R, Addenbrooke's Cognitive Examination-Revised; ACG, active control group; DSB, Digit Span Backward tests; DSF, Digit Span Forward tests; DSST, Digit Symbol Substitution Test; FAS, F-A-S Phonemic Verbal Fluency test; PCG, passive control group; SD, standard deviation; SKT, Syndrom Kurztest (Short Cognitive Test Performance); SSF, Spatial Span Forward test; SSB, Spatial Span Backward test; TG, training group; TMT A, Trail-Making Test A; TMT B, Trail-Making Test B.


Note: a p-value from the Kruskal-Wallis test.


No significant group differences were found regarding the psychosocial instruments, except for the GDS, in which the TG scored higher on depressive symptoms than the other groups ([Table 3]).

Table 3

Sample characteristics for performance on psychosocial variables

Variables

Group

Mean

±SD

Minimum

Median

Maximum

p-value

CFI

TG

3.97

±2.68

0.00

3.50

11.00

0.114ª

ACG

3.10

±2.09

0.00

2.50

8.00

PCG

3.11

±2.29

0.00

3.00

11.50

DASS

TG

19.35

±13.44

0.00

16.00

62.00

0.069ª

ACG

15.59

±11.19

0.00

14.00

52.00

PCG

14.10

±9.06

0.00

12.00

48.00

DASS: stress

TG

11.29

±6.75

0.00

10.00

34.00

0.079ª

ACG

9.49

±6.29

0.00

8.00

22.00

PCG

8.86

±5.86

0.00

8.00

32.00

DASS: anxiety

TG

4.40

±5.04

0.00

4.00

26.00

0.108ª

ACG

3.08

±4.25

0.00

2.00

26.00

PCG

2.71

±2.79

0.00

2.00

12.00

DASS: depression

TG

3.66

±4.56

0.00

2.00

26.00

0.139ª

ACG

3.02

±4.57

0.00

2.00

26.00

PCG

2.53

±3.69

0.00

2.00

18.00

GDS

TG

2.88

±2.07

0.00

3.00

9.00

0.047ª

ACG

2.40

±1.92

0.00

2.00

9.00

PCG

2.00

±1.55

0.00

2.00

6.00

CASP-19

TG

42.85

±7.38

23.00

44.00

56.00

0.823ª

ACG

43.56

±7.27

28.00

44.00

57.00

PCG

43.76

±7.08

27.00

43.00

57.00

CASP-19: control

TG

9.55

±1.56

6.00

10.00

12.00

0.300ª

ACG

9.81

±1.58

5.00

10.00

12.00

PCG

9.97

±1.46

5.00

10.00

12.00

CASP-19: autonomy

TG

10.89

±2.02

7.00

11.00

14.00

0.469ª

ACG

11.16

±2.17

5.00

11.00

15.00

PCG

11.29

±2.21

6.00

11.00

15.00

CASP-19: pleasure

TG

12.49

±2.59

5.00

13.00

15.00

0.728ª

ACG

12.46

±2.26

6.00

13.00

15.00

PCG

12.42

±2.08

8.00

12.00

15.00

CASP-19: self-realization

TG

9.91

±2.82

3.00

10.00

15.00

0.936ª

ACG

10.13

±2.89

5.00

10.00

15.00

PCG

10.08

±3.00

3.00

10.00

15.00

MMROI (number of registers)

TG

29.26

±16.57

4.00

27.00

100.00

0.120ª

ACG

24.60

±12.65

6.00

22.00

69.00

PCG

25.92

±14.50

3.00

24.00

94.00

Abbreviations: ACG, active control group; CASP-19, Control, Autonomy, Self-realization and Pleasure scale; CFI, Cognitive Function Instrument; DASS, Depression, Anxiety and Stress Scale; GDS, Geriatric Depression Scale; MMROI, Minimum Map of Relationship of Older Individuals; PCG, passive control group; SD, standard deviation; TG, training group.


Note: a p-value from the Kruskal-Wallis test, followed by post hoc multiple comparisons when p < 0.05, in GDS (TG ≠ PCG).



#

DISCUSSION

The objective of the present study was to describe the design of the Supera Cognitive Stimulation Study clinical trial and report the initial results collected at baseline. The results revealed that the different groups were similar in terms of sociodemographic, mood, cognitive, and functional variables. In randomized clinical trials, baseline evaluation is a key stage of the investigation.[4] The initial assessment is performed to identify whether there is any significant difference between the groups to be compared that may influence outcomes. The results of the present study suggest the randomization strategy adopted was effective.

The use of multicomponent strategies for cognitive stimulation in older adults has been the focus of previous studies using different intervention times, strategy types and follow-up intervals to measure maintenance of effects, as outlined in the summary by Brum and Yassuda.[37] Although their methodologies differed, these studies typically comprised only two groups: an experimental group and a control (generally passive) group. This highlights the need for studies in the field of cognitive stimulation involving older subjects that include the use of an active control group. This approach ensures a valid comparison between the effects of cognitive stimulation interventions and those of other activities or alternative interventions, helps control confounding variables which may influence study outcomes, improves the interpretation of results, and makes the study findings more generalizable for real-world situations.[4]

Lira et al.[38] investigated the effects of a cognitive stimulation program on healthy older adults. The sample comprised 32 older individuals, stratified into an experimental group and a control group. The two groups were homogenous regarding age, gender, and level of schooling on the baseline tests, and no differences in performance were found. After 10 sessions (of 120 minutess each) of cognitive stimulation, the cognitive intervention group presented better performance in terms of language and cognitive functions, as well as fewer memory complaints compared with the control group.

Gómez-Soria et al.[4] examined the effect of cognitive stimulation on older individuals, focusing on general cognitive functioning and specific cognitive domains. The results have revealed significant improvements in general cognitive functioning, memory, orientation, praxis, and calculus. Moreover, evidence suggests that traditional or computer-based cognitive stimulation programs, with sessions of 45 minutes or longer, can be more effective for memory improvement memory. Reports suggest that participants aged up to 75 years benefit the most from cognitive stimulation in several aspects of cognition. These findings have important implications for the clinical practice, underscoring the importance of personalized/adapted cognitive stimulation for optimal improvements in cognitive function in older adults.

Employing a different approach, another study[5] explored the effects of cognitive stimulation on older individuals, focusing on psychosocial results, such as quality of life, activities of daily living, mood (depression and anxiety), self-esteem, and loneliness. The cognitive stimulation interventions presented a significant association with higher quality of life in healthy older participants. However, the results suggest that cognitive stimulation appeared to have no significant impact on the levels of anxiety and depression or activities of daily living. Nevertheless, the study[5] also addressed issues related to the duration and format of cognitive stimulation programs, such as the efficacy of cognitive stimulation used in different cultural contexts and in combination with pharmacological treatment.

Regarding the present study, the test results showed similar performance across all 3 groups of participants. Moreover, although a change in the level of depressive symptoms was evident, this was not accompanied by any significant group differences in terms of quality of life or cognitive functions. The limitations to the current study included the gender bias of the sample, which contained a greater proportion of female than male subjects (73.43% versus 26.57% respectively). This gender imbalance, together with the strict inclusion and exclusion criteria, may limit the generalization of the current results to future clinical trials involving a large sample of older adults. Another limitation was the use of self-reported exclusion criteria, which may have affected sample representativeness. Additionally, the Braztel-MMSE tool was used to determine the cut-off to exclude individuals with possible dementia. However, the sample had a level of schooling higher than that of the original validation sample, potentially including individuals with mild cognitive impairment whose symptoms may have been masked. This limitation should be considered when interpreting the results.

Therefore, the results obtained at study baseline serve as key indicators that should be considered in subsequent statistical analyses to guarantee the validity of the results in subsequent stages of the study. Moreover, it is important to note that the results on the different tests applied, such as the FAS and TMT, showed no statistical difference among the groups analyzed.

The designs of studies on neuroplasticity show this to be fertile ground for basic research, in that it yields vital information on human aging. In summary, this evidence shows that cognitive interventions to improve performance on mnemonic tasks are important for the functioning of older individuals, such as remembering to take medications, paying bills, and preparing balanced meals, thereby contributing to independence and reducing the risk of institutionalization and mortality.

Future studies should acknowledge the baseline assessment as a fundamental step in guaranteeing the validity of results. Lastly, similar studies should be conducted involving larger, more diverse samples and employing other measures, such as analysis of biological markers in clinical trials involving cognitive interventions.


#
#

Conflict of interest

The authors have no conflict of interest to declare.

Authors' Contributions

Conceptualization: TBLS, SMDB, MSY; Data curation: TNO; Investigation: TBLS, TNO, GDS, LAC, APBM, DSB; Methodology: TBLS, APBM, SMDB, MSY; Writing – original draft: TBLS, TNO, GDS, LAC, APBM; Writing – review & editing: TBLS, TNO, GDS, APBM, DSB, MAAS, SAS, SMDB, MSY.


Data Availability Statement

Data is available on demand.


Editor-in-Chief: Hélio A. G. Teive (https://orcid.org/0000-0003-2305-1073).


Associate Editor: Leonardo Cruz de Souza (https://orcid.org/0000-0001-5027-9722).


  • References

  • 1 Bonfanti L, Charvet CJ. Brain Plasticity in Humans and Model Systems: Advances, Challenges, and Future Directions. Int J Mol Sci 2021; 22 (17) 9358
  • 2 Gavelin HM, Lampit A, Hallock H, Sabatés J, Bahar-Fuchs A. Cognition-Oriented Treatments for Older Adults: a Systematic Overview of Systematic Reviews. Neuropsychol Rev 2020; 30 (02) 167-193
  • 3 Webb SL, Birney DP, Loh V, Walker S, Lampit A, Bahar-Fuchs A. Cognition-oriented treatments for older adults: A systematic review of the influence of depression and self-efficacy individual differences factors. Neuropsychol Rehabil 2022; 32 (06) 1193-1229
  • 4 Gómez-Soria I, Iguacel I, Aguilar-Latorre A, Peralta-Marrupe P, Latorre E, Zaldívar JNC, Calatayud E. Cognitive stimulation and cognitive results in older adults: A systematic review and meta-analysis. Arch Gerontol Geriatr 2023; 104: 104807
  • 5 Gómez-Soria I, Iguacel I, Cuenca-Zaldívar JN, Aguilar-Latorre A, Peralta-Marrupe P, Latorre E, Calatayud E. Cognitive stimulation and psychosocial results in older adults: A systematic review and meta-analysis. Arch Gerontol Geriatr 2023; 115: 105114
  • 6 Calatayud E, Gómez-Cabello A, Gómez-Soria I. Análisis del efecto de un programa de estimulación cognitiva en adultos mayores con cognición normal: ensayo clínico aleatorizado. An Sist Sanit Navar 2021; 44 (03) 361-372
  • 7 Gomes ECC, Souza SL, Marques APO, Leal MCC. Treino de estimulação de memória e a funcionalidade do idoso sem comprometimento cognitivo: uma revisão integrativa. Cien Saude Colet 2020; 25 (06) 2193-2202
  • 8 Gómez-Soria I, Cuenca-Zaldívar JN, Rodríguez-Roca B, Subirón-Valera AB, Salavera C, Marcén-Román Y. et al. Cognitive Effects of a Cognitive Stimulation Programme on Trained Domains in Older Adults with Subjective Memory Complaints: Randomised Controlled Trial. Int J Environ Res Public Health 2023; 20 (04) 3636
  • 9 Coley N, Giulioli C, Aisen PS, Vellas B, Andrieu S. Randomised controlled trials for the prevention of cognitive decline or dementia: A systematic review. Ageing Res Rev 2022; 82: 101777
  • 10 Crivelli L, Calandri IL, Suemoto CK, Salinas RM, Velilla LM, Yassuda MS. et al. Latin American Initiative for Lifestyle Intervention to Prevent Cognitive Decline (LatAm-FINGERS): Study design and harmonization. Alzheimers Dement 2023; 19 (09) 4046-4060
  • 11 Brinke LFT, Best JR, Crockett RA, Liu-Ambrose T. The effects of an 8-week computerized cognitive training program in older adults: a study protocol for a randomized controlled trial. BMC Geriatr 2018; 18 (01) 31
  • 12 Kivipelto M, Solomon A, Ahtiluoto S, Ngandu T, Lehtisalo J, Antikainen R. et al. The Finnish geriatric intervention study to prevent cognitive impairment and disability (FINGER): study design and progress. Alzheimers Dement 2013; 9 (06) 657-665
  • 13 Jobe JB, Smith DM, Ball K, Tennstedt SL, Marsiske M, Willis SL. et al. ACTIVE: a cognitive intervention trial to promote independence in older adults. Control Clin Trials 2001; 22 (04) 453-479
  • 14 Zülke A, Luck T, Pabst A, Hoffmann W, Thyrian JR, Gensichen J. et al. AgeWell.de - study protocol of a pragmatic multi-center cluster-randomized controlled prevention trial against cognitive decline in older primary care patients. BMC Geriatr 2019; 19 (01) 203
  • 15 Yoon JS, Roque NA, Andringa R, Harrell ER, Lewis KG, Vitale T. et al. Intervention comparative effectiveness for adult cognitive training (ICE-ACT) trial: rationale, design, and baseline characteristics. Contemp Clin Trials 2019; 78: 76-87
  • 16 Kang M, Ragan BG, Park JH. Issues in outcomes research: an overview of randomization techniques for clinical trials. J Athl Train 2008; 43 (02) 215-221
  • 17 Camozzato AL, Kochhann R, Godinho C, Costa A, Chaves ML. Validation of a telephone screening test for Alzheimer's disease. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn 2011; 18 (02) 180-194
  • 18 Paradela EMP, Lourenço RA, Veras RP. Validação da escala de depressão geriátrica em um ambulatório geral. Rev Saude Publica 2005; 39 (06) 918-923
  • 19 Martiny C, Silva ACDO, Nardi AE, Pachana NA. Tradução e adaptação transcultural da versão brasileira do Inventário de Ansiedade Geriátrica (GAI). Arch Clin Psychiatry 2011; 38: 08-12
  • 20 Pfeffer RI, Kurosaki TT, Harrah Jr CH, Chance JM, Filos S. Measurement of functional activities in older adults in the community. J Gerontol 1982; 37 (03) 323-329
  • 21 Johnson EE, Hamer R, Nora RM, Tan B, Eisenstein N, Engelhart C. The Lie/Bet Questionnaire for screening pathological gamblers. Psychol Rep 1997; 80 (01) 83-88
  • 22 Castells MA, Furlanetto LM. Validity of the CAGE questionnaire for screening alcohol-dependent inpatients on hospital wards. Rev Bras Psiquiatr 2005; 27 (01) 54-57
  • 23 Amaral-Carvalho V, Lima-Silva TB, Mariano LI, Souza LCd, Guimarães HC, Bahia VS. et al. Brazilian Version of Addenbrooke's Cognitive Examination-Revised in the Differential Diagnosis of Alzheimer'S Disease and Behavioral Variant Frontotemporal Dementia. Arch Clin Neuropsychol 2022; 37 (02) 437-448
  • 24 Flaks MK, Forlenza OV, Pereira FS, Viola LF, Yassuda MS. Short cognitive performance test: diagnostic accuracy and education bias in older Brazilian adults. Arch Clin Neuropsychol 2009; 24 (03) 301-306
  • 25 Machado TH, Fichman HC, Santos EL, Carvalho VA, Fialho PP, Koenig AM. et al. Normative data for healthy elderly on the phonemic verbal fluency task - FAS. Dement Neuropsychol 2009; 3 (01) 55-60
  • 26 Wechsler D. WAIS-III: Wechsler Adult Intelligence Scale – Third Edition. San Antonio, TX: The Psychological Corporation; 1997
  • 27 Nascimento E. Adaptação, validação e normatização do WAIS-III para uma amostra brasileira. In: Wechsler D. WAIS-III: Manual para administração e avaliação. São Paulo: Casa do Psicólogo; 2004
  • 28 Wilde NJ, Strauss E, Tulsky DS. Memory span on the Wechsler scales. J Clin Exp Neuropsychol 2004; 26 (04) 539-549
  • 29 Lezak MD. Principles of Neuropsychological Assessment. In: Feinberg TE, Farah MJ. editors. Behavioral Neurology and Neuropsychology. New York: McGraw-Hill; 1997
  • 30 Arbuthnott K, Frank J. Trail making test, part B as a measure of executive control: validation using a set-switching paradigm. J Clin Exp Neuropsychol 2000; 22 (04) 518-528
  • 31 Santos GD, Ordonez TN, Costa LA, Souza MAAd, Cardoso NP, Lessa PP. et al. Análise de reprodutibilidade do teste de cálculos do ábaco em pessoas idosas saudáveis. Rev Kairos 2024; 27 (03) 95-114
  • 32 Martins BG, Silva WR, Maroco J, Campos JADB. Escala de Depressão, Ansiedade e Estresse: propriedades psicométricas e prevalência das afetividades. J Bras Psiquiatr 2019; 68: 32-41
  • 33 Neri AL, Borim FSA, Batistoni SST, Cachioni M, Rabelo DF, Fontes AP, Yassuda MS. Nova validação semântico-cultural e estudo psicométrico da CASP-19 em adultos e idosos brasileiros. Cad Saude Publica 2018; 34 (10) e00181417
  • 34 Duarte YAO, Domingues MAR. Validação do Mapa Mínimo de Relações Modificado e Adaptado. In: Duarte YAO, Domingues MAR. Família, rede de suporte social e idosos: instrumentos de avaliação. São Paulo: Blucher; 2020: 183-227
  • 35 Studart-Neto A, Moraes NC, Spera RR, Merlin SS, Parmera JB, Jaluul O. et al. Translation, cross-cultural adaptation, and validity of the Brazilian version of the Cognitive Function Instrument. Dement Neuropsychol 2022; 16 (01) 79-88
  • 36 Silva TBL, Santos G, Zumkeller MG, Barbosa MEdC, Moreira APB, Ordonez TN. et al. Intervenção cognitiva de longa duração com componentes multifatoriais: um estudo de descrição do Método Supera. Rev Kairos 2021; 24: 117-140
  • 37 Brum PS, Yassuda MS. Intervenções cognitivas para idosos. In: Freitas EV, Py L. editors. Tratado de geriatria e gerontologia. 5th ed.. Rio de Janeiro: Guanabara Koogan; 2022: 1266-1275
  • 38 Lira JO, Rugene OT, Mello PCH. Desempenho de idosos em testes específicos: efeito de Grupo de Estimulação. Rev Bras Geriatr Gerontol 2011; 14 (02) 209-220 Available from: https://www.scielo.br/j/rbgg/a/Y4ZKK4NXBZhgDcXvhL7fLbR/?format=pdf&lang=pt

Address for correspondence

Thais Bento Lima da Silva

Publication History

Received: 11 October 2024

Accepted: 28 April 2025

Article published online:
02 July 2025

© 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution 4.0 International License, permitting copying and reproduction so long as the original work is given appropriate credit (https://creativecommons.org/licenses/by/4.0/)

Thieme Revinter Publicações Ltda.
Rua Rego Freitas, 175, loja 1, República, São Paulo, SP, CEP 01220-010, Brazil

Bibliographical Record
Thais Bento Lima da Silva, Tiago Nascimento Ordonez, Gabriela dos Santos, Laydiane Alves Costa, Ana Paula Bagli Moreira, Diana dos Santos Bacelar, Maria Antonia Antunes de Souza, Sabrina Aparecida da Silva, Sonia Maria Dozzi Brucki, Monica Sanches Yassuda. Supera cognitive stimulation study with cognitively-unimpaired older adults: methodology and initial results of a randomized controlled clinical trial. Arq Neuropsiquiatr 2025; 83: s00451809882.
DOI: 10.1055/s-0045-1809882
  • References

  • 1 Bonfanti L, Charvet CJ. Brain Plasticity in Humans and Model Systems: Advances, Challenges, and Future Directions. Int J Mol Sci 2021; 22 (17) 9358
  • 2 Gavelin HM, Lampit A, Hallock H, Sabatés J, Bahar-Fuchs A. Cognition-Oriented Treatments for Older Adults: a Systematic Overview of Systematic Reviews. Neuropsychol Rev 2020; 30 (02) 167-193
  • 3 Webb SL, Birney DP, Loh V, Walker S, Lampit A, Bahar-Fuchs A. Cognition-oriented treatments for older adults: A systematic review of the influence of depression and self-efficacy individual differences factors. Neuropsychol Rehabil 2022; 32 (06) 1193-1229
  • 4 Gómez-Soria I, Iguacel I, Aguilar-Latorre A, Peralta-Marrupe P, Latorre E, Zaldívar JNC, Calatayud E. Cognitive stimulation and cognitive results in older adults: A systematic review and meta-analysis. Arch Gerontol Geriatr 2023; 104: 104807
  • 5 Gómez-Soria I, Iguacel I, Cuenca-Zaldívar JN, Aguilar-Latorre A, Peralta-Marrupe P, Latorre E, Calatayud E. Cognitive stimulation and psychosocial results in older adults: A systematic review and meta-analysis. Arch Gerontol Geriatr 2023; 115: 105114
  • 6 Calatayud E, Gómez-Cabello A, Gómez-Soria I. Análisis del efecto de un programa de estimulación cognitiva en adultos mayores con cognición normal: ensayo clínico aleatorizado. An Sist Sanit Navar 2021; 44 (03) 361-372
  • 7 Gomes ECC, Souza SL, Marques APO, Leal MCC. Treino de estimulação de memória e a funcionalidade do idoso sem comprometimento cognitivo: uma revisão integrativa. Cien Saude Colet 2020; 25 (06) 2193-2202
  • 8 Gómez-Soria I, Cuenca-Zaldívar JN, Rodríguez-Roca B, Subirón-Valera AB, Salavera C, Marcén-Román Y. et al. Cognitive Effects of a Cognitive Stimulation Programme on Trained Domains in Older Adults with Subjective Memory Complaints: Randomised Controlled Trial. Int J Environ Res Public Health 2023; 20 (04) 3636
  • 9 Coley N, Giulioli C, Aisen PS, Vellas B, Andrieu S. Randomised controlled trials for the prevention of cognitive decline or dementia: A systematic review. Ageing Res Rev 2022; 82: 101777
  • 10 Crivelli L, Calandri IL, Suemoto CK, Salinas RM, Velilla LM, Yassuda MS. et al. Latin American Initiative for Lifestyle Intervention to Prevent Cognitive Decline (LatAm-FINGERS): Study design and harmonization. Alzheimers Dement 2023; 19 (09) 4046-4060
  • 11 Brinke LFT, Best JR, Crockett RA, Liu-Ambrose T. The effects of an 8-week computerized cognitive training program in older adults: a study protocol for a randomized controlled trial. BMC Geriatr 2018; 18 (01) 31
  • 12 Kivipelto M, Solomon A, Ahtiluoto S, Ngandu T, Lehtisalo J, Antikainen R. et al. The Finnish geriatric intervention study to prevent cognitive impairment and disability (FINGER): study design and progress. Alzheimers Dement 2013; 9 (06) 657-665
  • 13 Jobe JB, Smith DM, Ball K, Tennstedt SL, Marsiske M, Willis SL. et al. ACTIVE: a cognitive intervention trial to promote independence in older adults. Control Clin Trials 2001; 22 (04) 453-479
  • 14 Zülke A, Luck T, Pabst A, Hoffmann W, Thyrian JR, Gensichen J. et al. AgeWell.de - study protocol of a pragmatic multi-center cluster-randomized controlled prevention trial against cognitive decline in older primary care patients. BMC Geriatr 2019; 19 (01) 203
  • 15 Yoon JS, Roque NA, Andringa R, Harrell ER, Lewis KG, Vitale T. et al. Intervention comparative effectiveness for adult cognitive training (ICE-ACT) trial: rationale, design, and baseline characteristics. Contemp Clin Trials 2019; 78: 76-87
  • 16 Kang M, Ragan BG, Park JH. Issues in outcomes research: an overview of randomization techniques for clinical trials. J Athl Train 2008; 43 (02) 215-221
  • 17 Camozzato AL, Kochhann R, Godinho C, Costa A, Chaves ML. Validation of a telephone screening test for Alzheimer's disease. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn 2011; 18 (02) 180-194
  • 18 Paradela EMP, Lourenço RA, Veras RP. Validação da escala de depressão geriátrica em um ambulatório geral. Rev Saude Publica 2005; 39 (06) 918-923
  • 19 Martiny C, Silva ACDO, Nardi AE, Pachana NA. Tradução e adaptação transcultural da versão brasileira do Inventário de Ansiedade Geriátrica (GAI). Arch Clin Psychiatry 2011; 38: 08-12
  • 20 Pfeffer RI, Kurosaki TT, Harrah Jr CH, Chance JM, Filos S. Measurement of functional activities in older adults in the community. J Gerontol 1982; 37 (03) 323-329
  • 21 Johnson EE, Hamer R, Nora RM, Tan B, Eisenstein N, Engelhart C. The Lie/Bet Questionnaire for screening pathological gamblers. Psychol Rep 1997; 80 (01) 83-88
  • 22 Castells MA, Furlanetto LM. Validity of the CAGE questionnaire for screening alcohol-dependent inpatients on hospital wards. Rev Bras Psiquiatr 2005; 27 (01) 54-57
  • 23 Amaral-Carvalho V, Lima-Silva TB, Mariano LI, Souza LCd, Guimarães HC, Bahia VS. et al. Brazilian Version of Addenbrooke's Cognitive Examination-Revised in the Differential Diagnosis of Alzheimer'S Disease and Behavioral Variant Frontotemporal Dementia. Arch Clin Neuropsychol 2022; 37 (02) 437-448
  • 24 Flaks MK, Forlenza OV, Pereira FS, Viola LF, Yassuda MS. Short cognitive performance test: diagnostic accuracy and education bias in older Brazilian adults. Arch Clin Neuropsychol 2009; 24 (03) 301-306
  • 25 Machado TH, Fichman HC, Santos EL, Carvalho VA, Fialho PP, Koenig AM. et al. Normative data for healthy elderly on the phonemic verbal fluency task - FAS. Dement Neuropsychol 2009; 3 (01) 55-60
  • 26 Wechsler D. WAIS-III: Wechsler Adult Intelligence Scale – Third Edition. San Antonio, TX: The Psychological Corporation; 1997
  • 27 Nascimento E. Adaptação, validação e normatização do WAIS-III para uma amostra brasileira. In: Wechsler D. WAIS-III: Manual para administração e avaliação. São Paulo: Casa do Psicólogo; 2004
  • 28 Wilde NJ, Strauss E, Tulsky DS. Memory span on the Wechsler scales. J Clin Exp Neuropsychol 2004; 26 (04) 539-549
  • 29 Lezak MD. Principles of Neuropsychological Assessment. In: Feinberg TE, Farah MJ. editors. Behavioral Neurology and Neuropsychology. New York: McGraw-Hill; 1997
  • 30 Arbuthnott K, Frank J. Trail making test, part B as a measure of executive control: validation using a set-switching paradigm. J Clin Exp Neuropsychol 2000; 22 (04) 518-528
  • 31 Santos GD, Ordonez TN, Costa LA, Souza MAAd, Cardoso NP, Lessa PP. et al. Análise de reprodutibilidade do teste de cálculos do ábaco em pessoas idosas saudáveis. Rev Kairos 2024; 27 (03) 95-114
  • 32 Martins BG, Silva WR, Maroco J, Campos JADB. Escala de Depressão, Ansiedade e Estresse: propriedades psicométricas e prevalência das afetividades. J Bras Psiquiatr 2019; 68: 32-41
  • 33 Neri AL, Borim FSA, Batistoni SST, Cachioni M, Rabelo DF, Fontes AP, Yassuda MS. Nova validação semântico-cultural e estudo psicométrico da CASP-19 em adultos e idosos brasileiros. Cad Saude Publica 2018; 34 (10) e00181417
  • 34 Duarte YAO, Domingues MAR. Validação do Mapa Mínimo de Relações Modificado e Adaptado. In: Duarte YAO, Domingues MAR. Família, rede de suporte social e idosos: instrumentos de avaliação. São Paulo: Blucher; 2020: 183-227
  • 35 Studart-Neto A, Moraes NC, Spera RR, Merlin SS, Parmera JB, Jaluul O. et al. Translation, cross-cultural adaptation, and validity of the Brazilian version of the Cognitive Function Instrument. Dement Neuropsychol 2022; 16 (01) 79-88
  • 36 Silva TBL, Santos G, Zumkeller MG, Barbosa MEdC, Moreira APB, Ordonez TN. et al. Intervenção cognitiva de longa duração com componentes multifatoriais: um estudo de descrição do Método Supera. Rev Kairos 2021; 24: 117-140
  • 37 Brum PS, Yassuda MS. Intervenções cognitivas para idosos. In: Freitas EV, Py L. editors. Tratado de geriatria e gerontologia. 5th ed.. Rio de Janeiro: Guanabara Koogan; 2022: 1266-1275
  • 38 Lira JO, Rugene OT, Mello PCH. Desempenho de idosos em testes específicos: efeito de Grupo de Estimulação. Rev Bras Geriatr Gerontol 2011; 14 (02) 209-220 Available from: https://www.scielo.br/j/rbgg/a/Y4ZKK4NXBZhgDcXvhL7fLbR/?format=pdf&lang=pt

Zoom Image
Figure 1 Diagram of the Consolidated Standards of Reporting Trials (CONSORT) statement.
Zoom Image
Figure 2 Model of the cognitive sessions.